Dr. Eva Kassi graduated from Aristotle University of Thessaloniki, Medical School in 1991. She then completed her internal medicine training and residency in Endocrinology, Diabetes and Metabolism at the Department of Endocrinology, Diabetes and Metabolic Diseases, “G.Gennimatas” General Hospital of Athens, and she became a certified endocrinologist. She was research fellow at the Department of Endocrinology and Metabolic Diseases at the University of Leiden, the Netherlands. She received PhD (2005) in Biochemistry. In 2006 she became Lecturer in the Department of Clinical Biochemistry, University General Hospital ‘Attikon’, Athens, Greece. Since 2011, she works as Associate Professor of Biochemisty/Molecular Endocrinology, in the Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens. She is author or coauthor of over 66 peer-reviewed publications (original, review, case reports and scientific letters) published in prestigious scientific journals, such as Circulation, Trends in Endocrinology and Metabolism, BMC Medicine, Oncotarget) as well as six international textbooks and electronic volumes (three chapters in EndoText.Ogr). She is member of the Editorial Board of ‘Hormones’ and ‘Journal of Geriatric Cardiology’. She currently serves as a regular peer-reviewer for several journals (more than 20), including International Journal of Cancer, Rheumatology, Journal of Endocrinology, PLoS One, European Journal of Endocrinology, Endocrine, Current Topics in Medicinal Chemistry. Her scientific research (project’s leader) has been funded by National Strategic Reference Framework (NSRF), by National and Kapodistrian University of Athens and by Hellenic Endocrine Society etc. My current research interests are focused on 1) the role of estrogens in the later stages of atheromatosis process and 2) the role of vitamin D in the glucocorticoid sensitivity.
Her research interest includes in the role of steroid hormones and steroid receptors in the pathophysiology of various diseases in humans. Clinical studies concern a) the role of estrogen receptor mutations and estrogen receptor signaling, in the aetiopathology of diseases such autoimmune diseases, breast cancer, osteoporosis, cardiovascular diseases, b) the interaction between insulin and adipocytokines in metabolic syndrome. In vitro studies concern evaluation of SERM-like activity of various plant extracts and natural/synthetic compounds.